The association of pre-treatment HPV subtypes with recurrence of VIN.

[1]  T. Lawrie,et al.  Medical and Surgical Treatments for Usual-Type Vulvar Intraepithelial Neoplasia. , 2016, JAMA Oncology.

[2]  S. Regauer,et al.  Human papilloma virus (HPV) – induced SQUAMOUS INTRAEPITHELIAL LESIONS in vulvar Lichen Planus , 2016, Geburtshilfe und Frauenheilkunde.

[3]  D. Galloway,et al.  Natural Antibodies to Human Papillomavirus 16 and Recurrence of Vulvar High-Grade Intraepithelial Neoplasia (VIN3) , 2016, Journal of lower genital tract disease.

[4]  F. Ghezzi,et al.  Local anesthetic versus forced coughing at colposcopic-guided biopsy: a prospective study. , 2014, European journal of obstetrics, gynecology, and reproductive biology.

[5]  H. Dickinson,et al.  Surgical interventions for high-grade vulval intraepithelial neoplasia. , 2014, The Cochrane database of systematic reviews.

[6]  Jubilee Brown,et al.  Vulvar intraepithelial neoplasia (VIN 2/3): comparing clinical outcomes and evaluating risk factors for recurrence. , 2012, Gynecologic oncology.

[7]  Enrique Lerma Puertas,et al.  Human Papillomavirus Detection by PCR Assay in a Large Series of High-Grade Squamous Intraepithelial Lesions with Cytohistological Correlation and Follow-Up , 2011, Acta Cytologica.

[8]  B. Clotet,et al.  Human Papillomavirus Genotype Distribution and Human Papillomavirus 16 and Human Papillomavirus 18 Genomic Integration in Invasive and In Situ Cervical Carcinoma in Human Immunodeficiency Virus-Infected Women , 2011, International Journal of Gynecologic Cancer.

[9]  R. Kurman,et al.  Human Papillomavirus Type-Distribution in Vulvar and Vaginal Cancers and Their Associated Precursors , 2009, Obstetrics and gynecology.

[10]  M. Madeleine,et al.  A Systematic Review of the Prevalence and Attribution of Human Papillomavirus Types among Cervical, Vaginal, and Vulvar Precancers and Cancers in the United States , 2008, Cancer Epidemiology Biomarkers & Prevention.

[11]  L. Huang,et al.  Integration of human papillomavirus type-16 and type-18 is a very early event in cervical carcinogenesis , 2007, Journal of Clinical Pathology.

[12]  E. Jenison,et al.  Surgical Treatments for Vulvar and Vaginal Dysplasia: A Randomized Controlled Trial , 2007, Obstetrics and gynecology.

[13]  P. Hillemanns,et al.  Integration of HPV-16 and HPV-18 DNA in vulvar intraepithelial neoplasia. , 2006, Gynecologic oncology.

[14]  A. Stewart,et al.  Vulvar Intraepithelial Neoplasia: Aspects of the Natural History and Outcome in 405 Women , 2005, Obstetrics and gynecology.

[15]  S. Modesitt,et al.  Vulvar Intraepithelial Neoplasia III: Occult Cancer and the Impact of Margin Status on Recurrence , 1998, Obstetrics and gynecology.

[16]  B. Monk,et al.  Prognostic significance of human papillomavirus DNA in vulvar carcinoma , 1995 .

[17]  A. Bryant,et al.  Medical interventions for high-grade vulval intraepithelial neoplasia. , 2015, The Cochrane database of systematic reviews.

[18]  A. D. de Craen,et al.  Is the assumed natural history of vulvar intraepithelial neoplasia III based on enough evidence? A systematic review of 3322 published patients. , 2005, Gynecologic oncology.